Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 728

1.

Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability.

Shoeibi A, Litvan I, Tolosa E, Ser TD, Lee E; TAUROS Investigators.

Parkinsonism Relat Disord. 2019 Jul 9. pii: S1353-8020(19)30300-1. doi: 10.1016/j.parkreldis.2019.07.010. [Epub ahead of print]

PMID:
31307919
2.

SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease.

Fernández-Santiago R, Martín-Flores N, Antonelli F, Cerquera C, Moreno V, Bandres-Ciga S, Manduchi E, Tolosa E, Singleton AB, Moore JH; International Parkinson's Disease Genomics Consortium, Martí MJ, Ezquerra M, Malagelada C.

Mov Disord. 2019 Jun 24. doi: 10.1002/mds.27770. [Epub ahead of print]

PMID:
31234232
3.

α-synuclein RT-QuIC in cerebrospinal fluid of LRRK2-linked Parkinson's disease.

Garrido A, Fairfoul G, Tolosa ES, Martí MJ, Green A; Barcelona LRRK2 Study Group.

Ann Clin Transl Neurol. 2019 May 9;6(6):1024-1032. doi: 10.1002/acn3.772. eCollection 2019 Jun.

4.

Inflammatory Phenotype of Intrahepatic Sulfatide-Reactive Type II NKT Cells in Humans With Autoimmune Hepatitis.

Sebode M, Wigger J, Filpe P, Fischer L, Weidemann S, Krech T, Weiler-Normann C, Peiseler M, Hartl J, Tolosa E, Herkel J, Schramm C, Lohse AW, Arrenberg P.

Front Immunol. 2019 May 28;10:1065. doi: 10.3389/fimmu.2019.01065. eCollection 2019.

5.

Mitochondrial and autophagic alterations in skin fibroblasts from Parkinson disease patients with Parkin mutations.

González-Casacuberta I, Juárez-Flores DL, Ezquerra M, Fucho R, Catalán-García M, Guitart-Mampel M, Tobías E, García-Ruiz C, Fernández-Checa JC, Tolosa E, Martí MJ, Grau JM, Fernández-Santiago R, Cardellach F, Morén C, Garrabou G.

Aging (Albany NY). 2019 Jun 9;11(11):3750-3767. doi: 10.18632/aging.102014.

6.

A critique of the second consensus criteria for multiple system atrophy.

Stankovic I, Quinn N, Vignatelli L, Antonini A, Berg D, Coon E, Cortelli P, Fanciulli A, Ferreira JJ, Freeman R, Halliday G, Höglinger GU, Iodice V, Kaufmann H, Klockgether T, Kostic V, Krismer F, Lang A, Levin J, Low P, Mathias C, Meissner WG, Kaufmann LN, Palma JA, Panicker JN, Pellecchia MT, Sakakibara R, Schmahmann J, Scholz SW, Singer W, Stamelou M, Tolosa E, Tsuji S, Seppi K, Poewe W, Wenning GK; Movement Disorder Society Multiple System Atrophy Study Group.

Mov Disord. 2019 Apr 29. doi: 10.1002/mds.27701. [Epub ahead of print] No abstract available.

PMID:
31034671
7.

Co-morbid demyelinating lesions and atypical clinical features in a patient with Parkinson's disease.

Rodriguez-Diehl R, Vilas D, Bargalló N, Tolosa E, Gelpi E.

Parkinsonism Relat Disord. 2019 May;62:242-245. doi: 10.1016/j.parkreldis.2019.01.015. Epub 2019 Feb 2. No abstract available.

PMID:
30738747
8.

Prenatal Betamethasone interferes with immune system development and alters target cells in autoimmune diabetes.

Perna-Barrull D, Rodriguez-Fernandez S, Pujol-Autonell I, Gieras A, Ampudia-Carrasco RM, Villalba A, Glau L, Tolosa E, Vives-Pi M.

Sci Rep. 2019 Feb 4;9(1):1235. doi: 10.1038/s41598-018-37878-9.

9.

Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder.

Chahine LM, Iranzo A, Fernández-Arcos A, Simuni T, Seedorff N, Caspell-Garcia C, Amara AW, Comella C, Högl B, Hamilton J, Marek K, Mayer G, Mollenhauer B, Postuma R, Tolosa E, Trenkwalder C, Videnovic A, Oertel W; PPMI Sleep Working Group.

NPJ Parkinsons Dis. 2019 Jan 29;5:2. doi: 10.1038/s41531-018-0073-1. eCollection 2019.

10.

Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease.

di Domenico A, Carola G, Calatayud C, Pons-Espinal M, Muñoz JP, Richaud-Patin Y, Fernandez-Carasa I, Gut M, Faella A, Parameswaran J, Soriano J, Ferrer I, Tolosa E, Zorzano A, Cuervo AM, Raya A, Consiglio A.

Stem Cell Reports. 2019 Feb 12;12(2):213-229. doi: 10.1016/j.stemcr.2018.12.011. Epub 2019 Jan 10.

11.

Myoclonus-Dominant Corticobasal Degeneration.

Caballol N, Navarro-Otano J, Ávila A, Balagué-Marmaña M, Martínez-Fernández R, de Fàbregas O, Gelpí E, Valls-Solé J, Tolosa E.

Mov Disord Clin Pract. 2018 Nov 6;5(6):649-652. doi: 10.1002/mdc3.12670. eCollection 2018 Nov-Dec. No abstract available.

PMID:
30637289
12.

Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming.

Koutsioumpa M, Hatziapostolou M, Polytarchou C, Tolosa EJ, Almada LL, Mahurkar-Joshi S, Williams J, Tirado-Rodriguez AB, Huerta-Yepez S, Karavias D, Kourea H, Poultsides GA, Struhl K, Dawson DW, Donahue TR, Fernández-Zapico ME, Iliopoulos D.

Gut. 2019 Jul;68(7):1271-1286. doi: 10.1136/gutjnl-2017-315690. Epub 2018 Oct 18.

PMID:
30337373
13.

Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine.

Fabbri M, Ferreira JJ, Lees A, Stocchi F, Poewe W, Tolosa E, Rascol O.

Mov Disord. 2018 Oct;33(10):1528-1539. doi: 10.1002/mds.27475. Epub 2018 Sep 27. Review.

PMID:
30264443
14.

Simultaneous low-frequency deep brain stimulation of the substantia nigra pars reticulata and high-frequency stimulation of the subthalamic nucleus to treat levodopa unresponsive freezing of gait in Parkinson's disease: A pilot study.

Valldeoriola F, Muñoz E, Rumià J, Roldán P, Cámara A, Compta Y, Martí MJ, Tolosa E.

Parkinsonism Relat Disord. 2019 Mar;60:153-157. doi: 10.1016/j.parkreldis.2018.09.008. Epub 2018 Sep 5.

15.

Alpha-synuclein aggregates in the parotid gland of idiopathic REM sleep behavior disorder.

Fernández-Arcos A, Vilaseca I, Aldecoa I, Serradell M, Tolosa E, Santamaría J, Gelpi E, Iranzo A.

Sleep Med. 2018 Dec;52:14-17. doi: 10.1016/j.sleep.2018.08.003. Epub 2018 Aug 14.

PMID:
30195197
16.

Lack of central and peripheral nervous system synuclein pathology in R1441G LRRK2-associated Parkinson's disease.

Vilas D, Gelpi E, Aldecoa I, Grau O, Rodriguez-Diehl R, Jaumà S, Martí MJ, Tolosa E.

J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):832-833. doi: 10.1136/jnnp-2018-318473. Epub 2018 Jul 27. No abstract available.

PMID:
30054313
17.

BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells.

Lessel D, Gehbauer C, Bramswig NC, Schluth-Bolard C, Venkataramanappa S, van Gassen KLI, Hempel M, Haack TB, Baresic A, Genetti CA, Funari MFA, Lessel I, Kuhlmann L, Simon R, Liu P, Denecke J, Kuechler A, de Kruijff I, Shoukier M, Lek M, Mullen T, Lüdecke HJ, Lerario AM, Kobbe R, Krieger T, Demeer B, Lebrun M, Keren B, Nava C, Buratti J, Afenjar A, Shinawi M, Guillen Sacoto MJ, Gauthier J, Hamdan FF, Laberge AM, Campeau PM, Louie RJ, Cathey SS, Prinz I, Jorge AAL, Terhal PA, Lenhard B, Wieczorek D, Strom TM, Agrawal PB, Britsch S, Tolosa E, Kubisch C.

Brain. 2018 Aug 1;141(8):2299-2311. doi: 10.1093/brain/awy173.

PMID:
29985992
18.

Validation of a simple screening tool for early diagnosis of advanced Parkinson's disease in daily practice: the CDEPA questionnaire.

Martinez-Martin P, Kulisevsky J, Mir P, Tolosa E, García-Delgado P, Luquin MR.

NPJ Parkinsons Dis. 2018 Jul 2;4:20. doi: 10.1038/s41531-018-0056-2. eCollection 2018.

19.

MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients.

Tolosa E, Botta-Orfila T, Morató X, Calatayud C, Ferrer-Lorente R, Martí MJ, Fernández M, Gaig C, Raya Á, Consiglio A, Ezquerra M, Fernández-Santiago R.

Neurobiol Aging. 2018 Sep;69:283-291. doi: 10.1016/j.neurobiolaging.2018.05.032. Epub 2018 May 31.

PMID:
29935433
20.

Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study.

Borm CDJM, Krismer F, Wenning GK, Seppi K, Poewe W, Pellecchia MT, Barone P, Johnsen EL, Østergaard K, Gurevich T, Djaldetti R, Sambati L, Cortelli P, Petrović I, Kostić VS, Brožová H, Růžička E, Marti MJ, Tolosa E, Canesi M, Post B, Nonnekes J, Bloem BR; European MSA Study Group (EMSA-SG).

Parkinsonism Relat Disord. 2018 Nov;56:33-40. doi: 10.1016/j.parkreldis.2018.06.015. Epub 2018 Jun 8.

PMID:
29910157
21.

Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2 G2019S -Parkinson's disease.

Juárez-Flores DL, González-Casacuberta I, Ezquerra M, Bañó M, Carmona-Pontaque F, Catalán-García M, Guitart-Mampel M, Rivero JJ, Tobias E, Milisenda JC, Tolosa E, Marti MJ, Fernández-Santiago R, Cardellach F, Morén C, Garrabou G.

J Transl Med. 2018 Jun 8;16(1):160. doi: 10.1186/s12967-018-1526-3.

22.

α-Synuclein aggregates in labial salivary glands of idiopathic rapid eye movement sleep behavior disorder.

Iranzo A, Borrego S, Vilaseca I, Martí C, Serradell M, Sánchez-Valle R, Kovacs GG, Valldeoriola F, Gaig C, Santamaria J, Tolosa E, Gelpi E.

Sleep. 2018 Aug 1;41(8). doi: 10.1093/sleep/zsy101.

PMID:
29790977
23.

CD39 is upregulated during activation of mouse and human T cells and attenuates the immune response to Listeria monocytogenes.

Raczkowski F, Rissiek A, Ricklefs I, Heiss K, Schumacher V, Wundenberg K, Haag F, Koch-Nolte F, Tolosa E, Mittrücker HW.

PLoS One. 2018 May 9;13(5):e0197151. doi: 10.1371/journal.pone.0197151. eCollection 2018.

24.

Clustering of motor and nonmotor traits in leucine-rich repeat kinase 2 G2019S Parkinson's disease nonparkinsonian relatives: A multicenter family study.

Mestre TA, Pont-Sunyer C, Kausar F, Visanji NP, Ghate T, Connolly BS, Gasca-Salas C, Kern DS, Jain J, Slow EJ, Faust-Socher A, Kasten M, Wadia PM, Zadikoff C, Kumar P, de Bie RM, Thomsen T, Lang AE, Schüle B, Klein C, Tolosa E, Marras C.

Mov Disord. 2018 Jul;33(6):960-965. doi: 10.1002/mds.27272. Epub 2018 Apr 17.

PMID:
29665080
25.

Extrastriatal monoaminergic dysfunction and enhanced microglial activation in idiopathic rapid eye movement sleep behaviour disorder.

Stokholm MG, Iranzo A, Østergaard K, Serradell M, Otto M, Bacher Svendsen K, Garrido A, Vilas D, Parbo P, Borghammer P, Santamaria J, Møller A, Gaig C, Brooks DJ, Tolosa E, Pavese N.

Neurobiol Dis. 2018 Jul;115:9-16. doi: 10.1016/j.nbd.2018.02.017. Epub 2018 Mar 6.

PMID:
29522818
26.

Tauopathy with Hippocampal 4-Repeat Tau Immunoreactive Spherical Inclusions in a Patient with PSP.

Borrego-Écija S, Grau-Rivera O, Colom-Cadena M, Molinuevo JL, Tolosa E, Sánchez-Valle R, Gelpi E.

Brain Pathol. 2018 Mar;28(2):284-286. doi: 10.1111/bpa.12506. No abstract available.

PMID:
29516660
27.

Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations.

González-Casacuberta I, Morén C, Juárez-Flores DL, Esteve-Codina A, Sierra C, Catalán-García M, Guitart-Mampel M, Tobías E, Milisenda JC, Pont-Sunyer C, Martí MJ, Cardellach F, Tolosa E, Artuch R, Ezquerra M, Fernández-Santiago R, Garrabou G.

Neurobiol Aging. 2018 May;65:206-216. doi: 10.1016/j.neurobiolaging.2018.01.021. Epub 2018 Feb 7. Erratum in: Neurobiol Aging. 2018 Sep;69:300.

PMID:
29501959
28.

Glucocerebrosidase gene variants are accumulated in idiopathic REM sleep behavior disorder.

Gámez-Valero A, Iranzo A, Serradell M, Vilas D, Santamaria J, Gaig C, Álvarez R, Ariza A, Tolosa E, Beyer K.

Parkinsonism Relat Disord. 2018 May;50:94-98. doi: 10.1016/j.parkreldis.2018.02.034. Epub 2018 Feb 21.

PMID:
29487000
29.

An observational study of rotigotine transdermal patch and other currently prescribed therapies in patients with Parkinson's disease.

Müller T, Tolosa E, Badea L, Asgharnejad M, Grieger F, Markowitz M, Nondonfaz X, Bauer L, Timmermann L.

J Neural Transm (Vienna). 2018 Jun;125(6):953-963. doi: 10.1007/s00702-018-1860-x. Epub 2018 Feb 26.

PMID:
29484495
30.

α-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain.

Fernández-Santiago R, Garrido A, Infante J, González-Aramburu I, Sierra M, Fernández M, Valldeoriola F, Muñoz E, Compta Y, Martí MJ, Ríos J, Tolosa E, Ezquerra M; Barcelona LRRK2 Study Group†.

Mov Disord. 2018 Apr;33(4):637-641. doi: 10.1002/mds.27295. Epub 2018 Feb 23.

PMID:
29473656
31.

Expanding the ADCY5 phenotype toward spastic paraparesis: A mutation in the M2 domain.

Waalkens AJE, Vansenne F, van der Hout AH, Zutt R, Mourmans J, Tolosa E, de Koning TJ, Tijssen MAJ.

Neurol Genet. 2018 Jan 24;4(1):e214. doi: 10.1212/NXG.0000000000000214. eCollection 2018 Feb. No abstract available.

32.

Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysis.

Uribe C, Segura B, Baggio HC, Abos A, Garcia-Diaz AI, Campabadal A, Marti MJ, Valldeoriola F, Compta Y, Tolosa E, Junque C.

Parkinsonism Relat Disord. 2018 May;50:3-9. doi: 10.1016/j.parkreldis.2018.02.006. Epub 2018 Feb 8.

33.

Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes.

Mohme M, Schliffke S, Maire CL, Rünger A, Glau L, Mende KC, Matschke J, Gehbauer C, Akyüz N, Zapf S, Holz M, Schaper M, Martens T, Schmidt NO, Peine S, Westphal M, Binder M, Tolosa E, Lamszus K.

Clin Cancer Res. 2018 Sep 1;24(17):4187-4200. doi: 10.1158/1078-0432.CCR-17-2617. Epub 2018 Feb 14.

PMID:
29444930
34.

Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson's disease patients.

Recasens A, Carballo-Carbajal I, Parent A, Bové J, Gelpi E, Tolosa E, Vila M.

Acta Neuropathol Commun. 2018 Feb 8;6(1):8. doi: 10.1186/s40478-018-0509-1.

35.

Target-enriched sequencing of chromosome 17q21.31 in sporadic tauopathies reveals no candidate variants.

Razquin C, Ortega-Cubero S, Rojo-Bustamante E, Diez-Fairen M, Lorenzo E, Alonso E, Ezquerra M, Ross OA, Carcel M, Lorenzo-Betancor O, Soto AI, Burgess JD, Ertekin-Taner N, Dickson DW, Pastor MA, Tolosa E, Pastor P.

Neurobiol Aging. 2018 Jun;66:177.e7-177.e10. doi: 10.1016/j.neurobiolaging.2017.12.026. Epub 2018 Jan 11.

PMID:
29398119
36.

Two-hundred Years Later: Is Parkinson's Disease a Single Defined Entity?

Rodríguez-Violante M, Cervantes-Arriaga A, Fahn S, Tolosa E.

Rev Invest Clin. 2017 Nov-Dec;69(6):308-313. doi: 10.24875/RIC.17002291. Review.

37.

IL-23 (Interleukin-23)-Producing Conventional Dendritic Cells Control the Detrimental IL-17 (Interleukin-17) Response in Stroke.

Gelderblom M, Gallizioli M, Ludewig P, Thom V, Arunachalam P, Rissiek B, Bernreuther C, Glatzel M, Korn T, Arumugam TV, Sedlacik J, Gerloff C, Tolosa E, Planas AM, Magnus T.

Stroke. 2018 Jan;49(1):155-164. doi: 10.1161/STROKEAHA.117.019101. Epub 2017 Dec 6.

PMID:
29212740
38.

l-Dopa/carbidopa intestinal gel and subthalamic nucleus stimulation: Effects on cognition and behavior.

Valldeoriola F, Santacruz P, Ríos J, Compta Y, Rumià J, Muñoz JE, Martí MJ, Tolosa E.

Brain Behav. 2017 Oct 20;7(11):e00848. doi: 10.1002/brb3.848. eCollection 2017 Nov.

39.

Prenatal Administration of Betamethasone Causes Changes in the T Cell Receptor Repertoire Influencing Development of Autoimmunity.

Gieras A, Gehbauer C, Perna-Barrull D, Engler JB, Diepenbruck I, Glau L, Joosse SA, Kersten N, Klinge S, Mittrücker HW, Friese MA, Vives-Pi M, Tolosa E.

Front Immunol. 2017 Nov 13;8:1505. doi: 10.3389/fimmu.2017.01505. eCollection 2017.

40.

Paracetamol Medication During Pregnancy: Insights on Intake Frequencies, Dosages and Effects on Hematopoietic Stem Cell Populations in Cord Blood From a Longitudinal Prospective Pregnancy Cohort.

Bremer L, Goletzke J, Wiessner C, Pagenkemper M, Gehbauer C, Becher H, Tolosa E, Hecher K, Arck PC, Diemert A, Tiegs G.

EBioMedicine. 2017 Dec;26:146-151. doi: 10.1016/j.ebiom.2017.10.023. Epub 2017 Nov 9.

41.

Clinical and neuropathological features of progressive supranuclear palsy in Leucine rich repeat kinase (LRRK2) G2019S mutation carriers.

Vilas D, Sharp M, Gelpi E, Genís D, Marder KS, Cortes E, Vonsattel JP, Tolosa E, Alcalay RN.

Mov Disord. 2018 Feb;33(2):335-338. doi: 10.1002/mds.27225. Epub 2017 Nov 9. No abstract available.

PMID:
29119599
42.

Caveats of Neurodegenerative Risk Stratification in Idiopathic REM Sleep Behavior Disorder by Use of the MDS Research for Prodromal Parkinson's Disease.

Mahlknecht P, Iranzo A, Stefani A, Serradell M, Santamaria J, Tolosa E, Högl B, Poewe W.

Sleep. 2017 Oct 1;40(10). doi: 10.1093/sleep/zsx131. No abstract available.

PMID:
28958020
43.

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ.

Mov Disord. 2017 Sep;32(9):1264-1310. doi: 10.1002/mds.27115. Review.

44.

Differential diagnosis between Parkinson's disease and essential tremor using the smartphone's accelerometer.

Barrantes S, Sánchez Egea AJ, González Rojas HA, Martí MJ, Compta Y, Valldeoriola F, Simo Mezquita E, Tolosa E, Valls-Solè J.

PLoS One. 2017 Aug 25;12(8):e0183843. doi: 10.1371/journal.pone.0183843. eCollection 2017.

45.

Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder.

Iranzo A, Santamaría J, Valldeoriola F, Serradell M, Salamero M, Gaig C, Niñerola-Baizán A, Sánchez-Valle R, Lladó A, De Marzi R, Stefani A, Seppi K, Pavia J, Högl B, Poewe W, Tolosa E, Lomeña F.

Ann Neurol. 2017 Sep;82(3):419-428. doi: 10.1002/ana.25026.

PMID:
28833467
46.

Proliferative capacity exhibited by human liver-resident CD49a+CD25+ NK cells.

Martrus G, Kautz T, Lunemann S, Richert L, Glau L, Salzberger W, Goebels H, Langeneckert A, Hess L, Poch T, Schramm C, Oldhafer KJ, Koch M, Tolosa E, Nashan B, Altfeld M.

PLoS One. 2017 Aug 9;12(8):e0182532. doi: 10.1371/journal.pone.0182532. eCollection 2017.

47.

Assessment of the HIV-1 reservoir in CD4+ regulatory T cells by a Droplet Digital PCR based approach.

Dunay GA, Solomatina A, Kummer S, Hüfner A, Bialek JK, Eberhard JM, Tolosa E, Hauber J, Schulze Zur Wiesch J.

Virus Res. 2017 Aug 15;240:107-111. doi: 10.1016/j.virusres.2017.07.008. Epub 2017 Jul 16.

PMID:
28720421
48.

Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.

Stokholm MG, Iranzo A, Østergaard K, Serradell M, Otto M, Svendsen KB, Garrido A, Vilas D, Borghammer P, Santamaria J, Møller A, Gaig C, Brooks DJ, Tolosa E, Pavese N.

Lancet Neurol. 2017 Oct;16(10):789-796. doi: 10.1016/S1474-4422(17)30173-4. Epub 2017 Jul 3.

PMID:
28684245
49.

A Novel p.Glu298Lys Mutation in the ACMSD Gene in Sporadic Parkinson's Disease.

Vilas D, Fernández-Santiago R, Sanchez E, Azcona LJ, Santos-Montes M, Casquero P, Argandoña L, Tolosa E, Paisán-Ruiz C.

J Parkinsons Dis. 2017;7(3):459-463. doi: 10.3233/JPD-171146.

PMID:
28671144
50.

Colonic Oxidative and Mitochondrial Function in Parkinson's Disease and Idiopathic REM Sleep Behavior Disorder.

Morén C, González-Casacuberta Í, Navarro-Otano J, Juárez-Flores D, Vilas D, Garrabou G, Milisenda JC, Pont-Sunyer C, Catalán-García M, Guitart-Mampel M, Tobías E, Cardellach F, Valldeoriola F, Iranzo A, Tolosa E.

Parkinsons Dis. 2017;2017:9816095. doi: 10.1155/2017/9816095. Epub 2017 Jun 4.

Supplemental Content

Loading ...
Support Center